ZAM-27775-35607
4 vaccinations
9 coded responses
25 check-ins
9 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 973 / OR
- Registered
- 2021-04-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Dose 1 — Moderna
-
2021-04-15
Registered in v-safe
-
2021-04-15
Survey response — day 21, dose 1MedDRA: Asthenia, Migraine, Nausea — Feeling: FairFree text: Minor nausea from a 3 day migraine, the nausea before today was debilitating which is not normal for my migraines which is why I feel it's prudent to mention it here.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Dose 2 — Moderna
-
2021-04-22
Survey response — day 0, dose 2MedDRA: Inhalation therapy — Feeling: Good · Site: Pain · HeadacheFree text: I had to use my nebulizer immediately after getting home from work. Normally I wouldn't be using my nebulizer for a few hours after getting home from work.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Survey response — days 1–6 daily, dose 2MedDRA: Migraine, Nausea — Feeling: Poor · Site: Pain · Fever · Headache, Nausea, Vomiting · Be unable to do your normal daily activitiesFree text: I have migraines and this was on last work my migraine levels. It was difficult to move without feeling nauseous. I'm finally feeling human now. But from 2am to 2pm I was not functional.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-26
- 2021-05-01
- 2021-05-09
- 2021-05-13
- 2021-05-20
- 2021-06-03
- 2021-07-22
- 2021-10-24
-
2021-10-25
Dose 3 — Pfizer-BioNTech
-
2021-10-27
Survey response — days 1–6 daily, dose 3MedDRA: Migraine, Nausea — Feeling: Good · Site: PainFree text: I had a migraine and felt nauseous on 10/26/2021.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Swelling, Itching · HeadacheAdult check-in
- 2021-11-10
- 2021-11-17
-
2021-12-06
Survey response — day 42, dose 3MedDRA: Migraine — Feeling: Poor · Be unable to do your normal daily activitiesFree text: I've had a migraine since Friday.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-20
Dose 4 — Pfizer-BioNTech
-
2022-04-25
Survey response — 6 months, dose 3MedDRA: Cough, Dyspnoea, Fatigue, Medical counselling, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Fatigue, coughing, runny nose, breathlessness · Healthcare visit (other): Waiting on an email from my doctorMedDRA releases: 2024-11 · check-in free text available
-
2022-04-25
Survey response — days 1–6 daily, dose 4MedDRA: Cough, Dyspnoea, Medical counselling, Rhinorrhoea — Feeling: Poor · Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): Breathlessness, coughing, runny nose · Healthcare visit (other): Waiting on an email back from my health care providerMedDRA releases: 2024-11 · check-in free text available
-
2022-04-25
Report sent to call center — days 1–6 daily, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-25
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-26
- 2022-05-04
- 2022-05-13
- 2022-05-20
-
2022-07-20
Survey response — 3 months, dose 4MedDRA: COVID-19, Migraine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I had covid-19. My migraines have increased in frequency.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-20
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-21
- 2022-07-21
- 2022-07-21
-
2022-10-19
Survey response — 6 months, dose 4MedDRA: Migraine, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Worsening migraines · Healthcare visit (other): Change of medicationMedDRA releases: 2024-11 · check-in free text available
-
2022-10-19
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-10-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Moderna | |
| 2 | 2021-04-22 | Moderna | |
| 3 | 2021-10-25 | Pfizer-BioNTech | No |
| 4 | 2022-04-20 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-25 | Successful 2022-10-20 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-04-25 | Successful 2022-10-20 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-07-20 | Successful 2022-10-20 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-10-19 | Successful 2022-10-20 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 7 — day 21, dose 1
Symptoms: Minor nausea from a 3 day migraine, the nausea before today was debilitating which is not normal for my migraines which is why I feel it's prudent to mention it here.
Release 7 — day 0, dose 2
Systemic reaction (other): I had to use my nebulizer immediately after getting home from work. Normally I wouldn't be using my nebulizer for a few hours after getting home from work.
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): I have migraines and this was on last work my migraine levels. It was difficult to move without feeling nauseous. I'm finally feeling human now. But from 2am to 2pm I was not functional.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): I had a migraine and felt nauseous on 10/26/2021.
Release 10 — day 42, dose 3
Symptoms: I've had a migraine since Friday.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Breathlessness, coughing, runny nose
Healthcare visit (other): Waiting on an email back from my health care provider
Release 11 — 6 months, dose 3
Symptoms: Fatigue, coughing, runny nose, breathlessness
Healthcare visit (other): Waiting on an email from my doctor
Release 12 — 3 months, dose 4
Symptoms: I had covid-19. My migraines have increased in frequency.
Release 12 — 6 months, dose 4
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Inhalation therapy | ✓ | ✓ | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release